Publication | Closed Access

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

Neuroimaging BiomarkersSchizophrenia CsfAlzheimer's DiseasePsychiatryApolipoprotein A1 LevelsSchizophreniaNeurochemical BiomarkersNeurologyNeuroscienceBiological PsychiatryBrain PathologyMedicinePsychotic DisorderIndependent Protein-profiling Studies